MEDAG is located at 13q12.3 and is known to act as an upstream regulator of peroxisome proliferator-activated receptor gamma (PPARG), which has been verified as a key regulator in adipose tissue and useful therapeutic target for T2DM. Here, MEDAG is linked to type 2 diabetes mellitus.